Aims Patients with heart failure ( HF ) randomized in controlled trials are generally selected
and do not fully represent the ‘real world’. The purpose of this study is to better describe the …

… Before discussing ways of encouraging compliance with guidelines, this section presents
evidence to show that there is room for improvement at all three stages of heart failure care. …

… of heart failure from a global perspective, by exploring the epidemiology of heart failure,
outlining evidence-… a graphical display of the ideal pathway for heart failure care, identifying …

… Interestingly, patients with a diagnosis of heart failure after a remote (>1 year) heart failure
admission had a profile and outcome that was between the recent HF hospitalization and …

… Heart failure (HF) is a major public health problem affecting more than 23 million patients
worldwide. Incidence and prevalence rates vary significantly according to the source of data, …

… In recent years, we have learned a great deal about the pathophysiology of heart failure, and
we … We see the best evidence to date that improved heart failure treatment has resulted in …

… Optimizing heart failure outcomes will require both the expansion of the evidence base for
… patients with heart failure (HF) and left ventricular systolic dysfunction (LVSD). Based on this …

… Causes of death in heart failure patients worldwide. a—proportion of all-cause deaths at 1
year; b—proportion of all-cause deaths at 5 years. CVD, cardiovascular death; HF, heart failure…

… An estimated 64.3 million people are living with heart failure worldwide. In developed
countries, the prevalence of known heart failure is generally estimated at 1% to 2% of the general …

… with symptomatic heart failure (stage C, with at least one episode of decompensated heart
failure in … We excluded patients with heart failure caused by severe valvular heart disease, life-…